These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36258218)

  • 21. The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast-enhanced magnetic resonance study.
    Weissler-Snir A; Hindieh W; Spears DA; Adler A; Rakowski H; Chan RH
    J Cardiovasc Electrophysiol; 2019 May; 30(5):651-657. PubMed ID: 30680853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and Progression of Late Gadolinium Enhancement in Children and Adolescents With Hypertrophic Cardiomyopathy.
    Axelsson Raja A; Farhad H; Valente AM; Couce JP; Jefferies JL; Bundgaard H; Zahka K; Lever H; Murphy AM; Ashley E; Day SM; Sherrid MV; Shi L; Bluemke DA; Canter CE; Colan SD; Ho CY
    Circulation; 2018 Aug; 138(8):782-792. PubMed ID: 29622585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitral annular plane systolic excursion is an easy tool for fibrosis detection by late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Doesch C; Sperb A; Sudarski S; Lossnitzer D; Rudic B; Tülümen E; Heggemann F; Schimpf R; Schoenberg SO; Borggrefe M; Papavassiliu T
    Arch Cardiovasc Dis; 2015; 108(6-7):356-66. PubMed ID: 25863428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Right ventricular hypertrophy is associated with cardiovascular events in hypertrophic cardiomyopathy: evidence from study with magnetic resonance imaging.
    Nagata Y; Konno T; Fujino N; Hodatsu A; Nomura A; Hayashi K; Nakamura H; Kawashiri MA; Yamagishi M
    Can J Cardiol; 2015 Jun; 31(6):702-8. PubMed ID: 25935883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrocardiography based prediction of hypertrophy pattern and fibrosis amount in hypertrophic cardiomyopathy: comparative study with cardiac magnetic resonance imaging.
    Park CH; Chung H; Kim Y; Kim JY; Min PK; Lee KA; Yoon YW; Kim TH; Lee BK; Hong BK; Rim SJ; Kwon HM; Choi EY
    Int J Cardiovasc Imaging; 2018 Oct; 34(10):1619-1628. PubMed ID: 29728953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypertrophic Cardiomyopathy Patients With Paroxysmal Atrial Fibrillation Have a High Burden of Left Atrial Fibrosis by Cardiac Magnetic Resonance Imaging.
    Sivalokanathan S; Zghaib T; Greenland GV; Vasquez N; Kudchadkar SM; Kontari E; Lu DY; Dolores-Cerna K; van der Geest RJ; Kamel IR; Olgin JE; Abraham TP; Nazarian S; Zimmerman SL; Abraham MR
    JACC Clin Electrophysiol; 2019 Mar; 5(3):364-375. PubMed ID: 30898240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apical aneurysm formation in apical hypertrophic cardiomyopathy: Pilot study with cardiac magnetic resonance.
    Yang K; Yu SQ; Chen XY; Song YY; Yang SJ; Cui C; Zhao KK; Wei MD; Lu MJ; Zhao SH
    Int J Cardiol; 2023 Jan; 371():480-485. PubMed ID: 36115439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients who do not fulfill criteria for hypertrophic cardiomyopathy but have unexplained giant T-wave inversion: a cardiovascular magnetic resonance mid-term follow-up study.
    Li S; He J; Xu J; Zhuang B; Wu B; Wei B; Huang J; Yin G; Chen X; Zhu Z; Wang H; Zhao S; Lu M
    J Cardiovasc Magn Reson; 2021 Jun; 23(1):67. PubMed ID: 34078401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel insights into diminished cardiac reserve in non-obstructive hypertrophic cardiomyopathy from four-dimensional flow cardiac magnetic resonance component analysis.
    Ashkir Z; Johnson S; Lewandowski AJ; Hess A; Wicks E; Mahmod M; Myerson S; Ebbers T; Watkins H; Neubauer S; Carlhäll CJ; Raman B
    Eur Heart J Cardiovasc Imaging; 2023 Aug; 24(9):1192-1200. PubMed ID: 37114738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Left ventricular diastolic function assessed with cardiovascular magnetic resonance imaging and exercise capacity in patients with non-obstructive hypertrophic cardiomyopathy.
    Małek LA; Chojnowska L; Kłopotowski M; Misko J; Dabrowski M; Kuśmierczyk-Droszcz B; Maczyńska R; Piotrowicz E; Ruzyłło W
    Kardiol Pol; 2009 Jan; 67(1):1-6; discussion 7-8. PubMed ID: 19253184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The regional myocardial microvascular dysfunction differences in hypertrophic cardiomyopathy patients with or without left ventricular outflow tract obstruction: assessment with first-pass perfusion imaging using 3.0-T cardiac magnetic resonance.
    Xu HY; Yang ZG; Sun JY; Wen LY; Zhang G; Zhang S; Guo YK
    Eur J Radiol; 2014 Apr; 83(4):665-72. PubMed ID: 24521610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex differences in cardiac magnetic resonance features in patients with hypertrophic cardiomyopathy.
    Nogales-Romo MT; Cecconi A; Olivera MJ; Caballero P; Hernández S; Jiménez-Borreguero LJ; Alfonso F
    Int J Cardiovasc Imaging; 2020 Sep; 36(9):1751-1759. PubMed ID: 32405733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spirito-Maron echocardiographic score: a marker for morphological and physiological assessment of patients with hypertrophic cardiomyopathy.
    Rangel I; Gonçalves A; de Sousa C; Correia AS; Pinho T; Madureira AJ; Martins E; Cardoso JS; Macedo F; Maciel MJ
    Echocardiography; 2014 Jul; 31(6):708-15. PubMed ID: 24460546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of apical pouches in hypertrophic cardiomyopathy using cardiac MRI.
    Kebed KY; Al Adham RI; Bishu K; Askew JW; Klarich KW; Oh JK; Julsrud PR; Foley TA; Glockner JF; Nishimura RA; Ommen SR; Anavekar NS
    Int J Cardiovasc Imaging; 2014 Mar; 30(3):591-7. PubMed ID: 24390362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Preserved Systolic Function.
    Mentias A; Raeisi-Giglou P; Smedira NG; Feng K; Sato K; Wazni O; Kanj M; Flamm SD; Thamilarasan M; Popovic ZB; Lever HM; Desai MY
    J Am Coll Cardiol; 2018 Aug; 72(8):857-870. PubMed ID: 30115224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left Atrial Mechanical Function and Global Strain in Hypertrophic Cardiomyopathy.
    Kim KJ; Choi HM; Yoon YE; Kim HL; Lee SP; Kim HK; Kim YJ; Cho GY; Zo JH; Sohn DW
    PLoS One; 2016; 11(6):e0157433. PubMed ID: 27336444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late enhanced computed tomography in Hypertrophic Cardiomyopathy enables accurate left-ventricular volumetry.
    Langer C; Both M; Harders H; Lutz M; Eden M; Kühl C; Sattler B; Jansen O; Schaefer P; Frey N
    Eur Radiol; 2015 Feb; 25(2):575-84. PubMed ID: 25316053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of left ventricular systolic and diastolic abnormalities in patients with hypertrophic cardiomyopathy using real-time three-dimensional echocardiography and two-dimensional speckle tracking imaging.
    Huang X; Yue Y; Wang Y; Deng Y; Liu L; Di Y; Sun S; Chen D; Fan L; Cao J
    Cardiovasc Ultrasound; 2018 Oct; 16(1):23. PubMed ID: 30285887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advanced myocardial characterization in hypertrophic cardiomyopathy: feasibility of CMR-based feature tracking strain analysis in a case-control study.
    Yang L; Zhang L; Cao S; Gao C; Xu H; Song T; Zhang X; Wang K
    Eur Radiol; 2020 Nov; 30(11):6118-6128. PubMed ID: 32588208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contemporary family screening in hypertrophic cardiomyopathy: the role of cardiovascular magnetic resonance.
    Huurman R; van der Velde N; Schinkel AFL; Hassing HC; Budde RPJ; van Slegtenhorst MA; Verhagen JMA; Hirsch A; Michels M
    Eur Heart J Cardiovasc Imaging; 2022 Aug; 23(9):1144-1154. PubMed ID: 35670722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.